cdmo.directory
← Compare landing

LOTTE Biologics vs Merck KGaA

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryLOTTE BiologicsMerck KGaA
SummaryLOTTE Biologics offers biologics CDMO services spanning process and analytical development, antibody manufacturing from clinical to commercial GMP, and bioconjugate manufacturing. Its operations are based at campuses in Syracuse, New York and Songdo, Incheon.Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Bioconjugation Services
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Data not yet provided.
Modalities
  • Biologics (Monoclonal Antibodies)
Data not yet provided.
Development capabilities
  • Analytical method development
Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
Data not yet provided.
Locations
  • Syracuse Bio Campus, Syracuse, New York, United States
  • Songdo Bio Campus, Incheon, Incheon, South Korea
  • Daejeon Bioprocessing Center, Daejeon, South Korea
CertificationsData not yet provided.Data not yet provided.

Find similar companies

LOTTE Biologics alternatives · Merck KGaA alternatives

Markdown mirror: /compare/lotte-biologics/merck-kgaa.md